Literature DB >> 6234367

A rabbit model of toxic shock syndrome: clinicopathological features.

R J Arko, J K Rasheed, C V Broome, F W Chandler, A L Paris.   

Abstract

The complete pathogenesis of toxic shock syndrome (TSS) has yet to be elucidated. Unmasking the complex interactions among bacterial products, host factors, and possibly tampon components requires a suitable in vivo model. For this purpose, subcutaneous chambers implanted in rabbits were inoculated with Staphylococcus aureus isolated from patients with TSS. Infected rabbits developed illness characterised by multisystem involvement that included periportal inflammation of the liver, erythrophagocytosis in the spleen and lymph nodes as well as extreme vascular dilatation and epithelial lesions similar to those described in patients with TSS. Concentrations of serum creatinine (P less than 0.03) and triglycerides (P less than 0.04) were significantly raised in rabbits infected with TSS strains compared with rabbits infected with non-TSS strains of S. aureus. Both TSS and non-TSS strains of S. aureus produced fever and diarrhoea, but TSS strains were significantly (P less than 0.05) more lethal and more likely to produce respiratory distress and lowered blood pressure. This model may help to prove or disprove proposed mechanisms for the development of TSS.

Entities:  

Mesh:

Year:  1984        PMID: 6234367     DOI: 10.1016/s0163-4453(84)93859-3

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody.

Authors:  G K Best; D F Scott; J M Kling; M R Thompson; L E Adinolfi; P F Bonventre
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

2.  Hormonal influence on experimental infections by a toxic shock strain of Staphylococcus aureus.

Authors:  G K Best; T O Abney; J M Kling; J J Kirkland; D F Scott
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 3.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model.

Authors:  J C de Azavedo; T J Foster; P J Hartigan; J P Arbuthnott; M O'Reilly; B N Kreiswirth; R P Novick
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

5.  Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.

Authors:  D F Scott; J M Kling; G K Best
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.

Authors:  M W Reeves; R J Arko; F W Chandler; N B Bridges
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

7.  Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus.

Authors:  M W Reeves; L Pine; J C Feeley; D E Wells
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

8.  Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.

Authors:  J K Rasheed; R J Arko; J C Feeley; F W Chandler; C Thornsberry; R J Gibson; M L Cohen; C D Jeffries; C V Broome
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

9.  Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo.

Authors:  P F Bonventre; M R Thompson; L E Adinolfi; Z A Gillis; J Parsonnet
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

10.  A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1.

Authors:  J Parsonnet; Z A Gillis; A G Richter; G B Pier
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.